✦ LIBER ✦

Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase

✍ Scribed by Shintaro Takao, Yutaka Tokuda, Toshiaki Saeki, Jumpei Funai, Masami Ishii, Shigemitsu Takashima

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of trastuzumab and gemcitabi

✍ R. Bartsch; C. Wenzel; U. Pluschnig; G. Altorjai; P. Dubsky; R. Scheurer; A. Rot 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Phase II Study of Trastuzumab plus Gemci

✍ Joyce A. O'Shaughnessy; Sasha Vukelja; Thomas Marsland; Gary Kimmel; Suresh Ratn 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Efficacy and safety of low-dose metronom

✍ P. Fedele; A. Marino; L. Orlando; P. Schiavone; A. Nacci; F. Sponziello; P. Rizz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 203 KB

18 SAFETY AND EFFICACY OF LOW DOSE METRO

✍ P. Fedele; L. Orlando; P. Schiavone; P. Rizzo; N. Calvani; A. Marino; M. D'Amico 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

AOSOP5 A PHASE 2 TRIAL OF SALVAGE TREATM

✍ Sym, S.J.; Hong, J.; Ahn, H.K.; Park, J.; Cho, E.K.; Lee, J.H.; Lee, W.; Baek, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase I study with a weekly 1 h infusion

✍ U. Klaassen; H. Wilke; D. Strumberg; W. Eberhardt; M. Korn; S. Seeber 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 277 KB